Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by gojotv!on Nov 30, 2021 5:30am
442 Views
Post# 34178881

RE:RE:RE:RE:RE:results are good

RE:RE:RE:RE:RE:results are good

Yes, longs' expectations have been beaten down... I suspect that the preliminary results were so good that most investors took them to be unreliable.
Yet, here we are... on a continuing upswing.
I'm guessing that, as the scales fall out of the market's eyes and investors big and small begin to realize that this is the cure. for. cancer...!!
Momentum will begin to climb. Who wouldn't want 50k TLT shares in their portfolio at this time and at these prices?
I'm willing to aim higher pricewise... I'm going to guess $5.00 by May, when BTD status is either achieved or pending, and more and more results like these pour in.
I've seen bigger pops for less in other tech stocks...
It's hard to wrap our heads around it, but yeah...
Cure. for. CANCER...!
GLTA longs!

menoalittle wrote: >> an FDA response in Q2.  Would be happy to break $1

quite frankly, I suspect news of a BTD app being submitted will take over twice that  

but, what do I know, eh?


 

<< Previous
Bullboard Posts
Next >>